equol has been researched along with Breast Cancer in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (6.38) | 18.7374 |
1990's | 6 (12.77) | 18.2507 |
2000's | 16 (34.04) | 29.6817 |
2010's | 17 (36.17) | 24.3611 |
2020's | 5 (10.64) | 2.80 |
Authors | Studies |
---|---|
Chen, JZ; Khan, MZI; Nazli, A; Uzair, M | 1 |
Doerge, DR; Helferich, WG; Hughes, JR; Iwaniec, UT; Song, H; Turner, RT | 1 |
Doihara, H; Hatono, M; Ikeda, H; Iwamoto, T; Kajiwara, Y; Kawada, K; Kochi, M; Shien, T; Suzawa, K; Suzuki, Y; Taira, N; Toyooka, S; Tsukioki, T; Yamamoto, H; Yamane, M | 1 |
Clark, CA; Curiel, TJ; Drerup, JM; Hu, Y; Jin, VX; Li, R; Li, T; Wu, B; Yang, J; Yuan, B | 1 |
Hod, R; Maniam, S; Mohd Nor, NH | 1 |
Rigalli, JP; Ruiz, ML; Scholz, PN; Tocchetti, GN; Weiss, J | 1 |
Allsopp, P; Magee, PJ; Rowland, IR; Samaletdin, A | 1 |
Asakura, S; Hirata, K; Kutomi, G; Minatoya, M; Mori, M; Nagata, Y; Otokozawa, S; Sugiyama, Y | 1 |
Ghavami, L; Goliaei, B; Nikoofar, A; Taghizadeh, B | 1 |
Byrne, C; Fang, CY; Kurzer, MS; Tseng, M | 1 |
Barnes, S; Krontiras, H; Nagy, TR; Virk-Baker, MK | 1 |
Borrero-Garcia, LD; Cruz-Collazo, A; de la Parra, C; Dharmawardhane, S; Schneider, RJ | 1 |
Belosay, A; Doerge, DR; Hartman, JA; Helferich, WG; Song, H; Wang, W; Yang, X; Zhang, Y | 1 |
Atkinson, C; Frankenfeld, CL; Gao, DL; Lampe, JW; Li, W; Lin, MG; Porter, PL; Ray, RM; Shannon, J; Stalsberg, H; Thomas, DB; Wähälä, K | 1 |
Aiello Bowles, EJ; Atkinson, C; Lampe, JW; Lehman, CD; Li, L; Newton, KM; Stanczyk, FZ; Westerlind, KC | 1 |
Ahn, WS; Bae, SM; Choi, EJ | 1 |
Bennetau-Pelissero, C; Carreau, C; Flouriot, G; Potier, M | 1 |
Du, J; Hu, C; Li, Z; Liu, H; Liu, Q; Qi, H; Wang, S; Wang, X | 1 |
Cao, R; Cao, Z; Ji, A; Li, D; Shi, J; Wang, F; Yang, R | 1 |
Hu, JW; Wang, PY; Zhang, YM; Zhao, XH | 1 |
Hayashi, S; Kato, K; Onoda, A; Uchiyama, S; Ueno, T; Wake, N | 1 |
Bernard-Gallon, D; Bignon, YJ; Bosviel, R; Déchelotte, P; Durif, J | 1 |
de la Parra, C; Dharmawardhane, S; Martinez-Montemayor, M; Otero-Franqui, E | 1 |
Bailey-Horne, VA; Brown, JE; Clarke, DB; Culliford, DJ; Lawrence, JM; Lloyd, AS; Parry, BM; Raats, M; Rainsbury, RM; Storey, L | 1 |
Arisaka, O; Evans, BA; Miyake, N; Morgan, LD; Morton, MS | 1 |
Adlercreutz, H; Bonorden, MJ; Feirtag, J; Greany, KA; Kurzer, MS; Phipps, WR; Wangen, KE | 1 |
Aiello, EJ; Frankenfeld, CL; Holt, VL; LaCroix, K; Lampe, JW; McTiernan, A; Schramm, J; Schwartz, SM; Thomas, WK | 1 |
Atkinson, C; Frankenfeld, CL; Lampe, JW | 1 |
Adlercreutz, H; Greany, KA; Kurzer, MS; Nettleton, JA; Thomas, W; Wangen, KE | 1 |
Anderson, KE; Grady, JJ; Lu, LJ; Nagamani, M; Nhan, S | 1 |
Allred, KF; Doerge, DR; Fultz, J; Helferich, WG; Ju, YH | 1 |
Lau, TY; Leung, LK | 1 |
Duffin, JG; Jokela, T; Magee, PJ; Pool-Zobel, BL; Raschke, M; Rowland, IR; Steiner, C; Wahala, K | 1 |
Constantinou, AI; Lim, SB; Tonetti, DA; Zhang, Y; Zhao, H | 1 |
Kashiki, Y; Nagao, Y; Nagata, C; Shibuya, C; Shimizu, H; Uchiyama, S; Ueno, T; Yamamoto, S | 1 |
Botting, N; Darbre, PD; Mills, S; Pope, GS; Pugazhendhi, D; Watson, KA | 1 |
Adlercreutz, H; Dwyer, JT; Fotsis, T; Goldin, BR; Gorbach, SL; Heikkinen, R; Woods, M | 1 |
Axelson, M; Borriello, SP; Hulme, P; Kirk, DN; Setchell, KD | 1 |
Duwe, G; Zava, DT | 1 |
Ingram, D; Kolybaba, M; Lopez, D; Sanders, K | 1 |
Sathyamoorthy, N; Wang, TT | 1 |
Frawley, LS; Willard, ST | 1 |
Adlercreutz, H; Akhmedkhanov, A; Toniolo, P; Zeleniuch-Jacquotte, A | 1 |
Custer, LJ; Dai, Q; Franke, AA; Jin, F; Shu, XO; Wen, WQ; Zheng, W | 1 |
Duncan, AM; Kurzer, MS; Merz-Demlow, BE; Phipps, WR; Xu, X | 1 |
Calaf, G; Jordan, VC; Koch, R; Murphy, CS; Welshons, WV | 1 |
5 review(s) available for equol and Breast Cancer
Article | Year |
---|---|
An overview on Estrogen receptors signaling and its ligands in breast cancer.
Topics: Breast Neoplasms; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; Ligands; Male; Receptors, Estrogen | 2022 |
A Systematic Review of the Effects of Equol (Soy Metabolite) on Breast Cancer.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Equol; Female; Humans; Mice, Inbred BALB C; Rats, Sprague-Dawley | 2021 |
Equol, adiponectin, insulin levels and risk of breast cancer.
Topics: Adiponectin; Breast Neoplasms; Case-Control Studies; Equol; Female; Humans; Hypoglycemic Agents; Insulin; Obesity; Phytoestrogens; Risk Factors | 2013 |
Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health.
Topics: Bacteria; Breast Neoplasms; Equol; Estrogens, Non-Steroidal; Female; Glycine max; Humans; Intestinal Mucosa; Intestines; Isoflavones; Male; Prostatic Neoplasms; Surveys and Questionnaires | 2005 |
Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease.
Topics: Adult; Bacteria; Benzopyrans; Breast Neoplasms; Chromans; Diet; Dietary Proteins; Digestive System; Equol; Estrogens; Estrogens, Non-Steroidal; Female; Glycine max; Humans; Isoflavones; Male; Neoplasms, Hormone-Dependent; Phytoestrogens; Plant Preparations; Risk | 1984 |
3 trial(s) available for equol and Breast Cancer
Article | Year |
---|---|
Consumption of Lactobacillus acidophilus and Bifidobacterium longum do not alter urinary equol excretion and plasma reproductive hormones in premenopausal women.
Topics: Adult; Bifidobacterium; Body Mass Index; Breast Neoplasms; Dehydroepiandrosterone Sulfate; Dietary Fiber; Equol; Estradiol; Female; Hormones; Humans; Isoflavones; Lactobacillus acidophilus; Menstrual Cycle; Phytoestrogens; Premenopause; Probiotics; Risk Factors | 2004 |
The effect of soy consumption on the urinary 2:16-hydroxyestrone ratio in postmenopausal women depends on equol production status but is not influenced by probiotic consumption.
Topics: Bifidobacterium; Breast Neoplasms; Equol; Estrogens; Feeding Behavior; Female; Glycine max; Humans; Hydroxyestrones; Isoflavones; Lactobacillus acidophilus; Middle Aged; Postmenopause; Probiotics; Reference Values | 2005 |
Effect of a soymilk supplement containing isoflavones on urinary F2 isoprostane levels in premenopausal women.
Topics: Adult; Age Factors; Aging; Breast Neoplasms; Cross-Over Studies; Dietary Supplements; Dose-Response Relationship, Drug; Equol; F2-Isoprostanes; Female; Genistein; Humans; Isoflavones; Lipid Peroxidation; Premenopause; Soy Milk | 2005 |
39 other study(ies) available for equol and Breast Cancer
Article | Year |
---|---|
(±)-Equol does not interact with genistein on estrogen-dependent breast tumor growth.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dietary Supplements; Equol; Female; Genistein; Humans; Mammary Glands, Animal; Mice, Inbred BALB C; Mice, Nude; Phytoestrogens | 2020 |
Effect of isoflavones on breast cancer cell development and their impact on breast cancer treatments.
Topics: Breast Neoplasms; Equol; Humans; Isoflavones; Neoplasm Recurrence, Local; Tamoxifen; Tumor Cells, Cultured | 2021 |
Estrogen receptor beta signaling in CD8
Topics: Animals; Breast Neoplasms; CD8-Positive T-Lymphocytes; Equol; Estrogen Receptor beta; Female; HEK293 Cells; Humans; Immune Checkpoint Inhibitors; Immunotherapy, Adoptive; Male; Mice; Mutation; Phosphotyrosine; Signal Transduction; Survival Analysis; Xenograft Model Antitumor Assays | 2021 |
The phytoestrogens daidzein and equol inhibit the drug transporter BCRP/ABCG2 in breast cancer cells: potential chemosensitizing effect.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Equol; Humans; Isoflavones; Neoplasm Proteins; Phytoestrogens; Polymerase Chain Reaction; Up-Regulation | 2019 |
Daidzein, R-(+)equol and S-(-)equol inhibit the invasion of MDA-MB-231 breast cancer cells potentially via the down-regulation of matrix metalloproteinase-2.
Topics: Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Equol; Female; Gene Expression Regulation, Neoplastic; Glycine max; Humans; Isoflavones; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2 | 2014 |
Equol as a potent radiosensitizer in estrogen receptor-positive and -negative human breast cancer cell lines.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; DNA Damage; Equol; Female; Humans; Radiation-Sensitizing Agents; Receptors, Estrogen | 2015 |
Equol-producing status, isoflavone intake, and breast density in a sample of U.S. Chinese women.
Topics: Adult; Aged; Breast; Breast Neoplasms; China; Cohort Studies; Diet; Equol; Female; Humans; Isoflavones; Longitudinal Studies; Middle Aged; Radiography; United States | 2013 |
S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
Topics: Aged; Biological Availability; Biopsy; Breast; Breast Neoplasms; Cross-Sectional Studies; Diet; Dietary Supplements; Equol; Estrogen Receptor beta; Feeding Behavior; Female; Glycine max; Humans; Isoflavones; Middle Aged; Odds Ratio; Phytoestrogens; Postmenopause; Soy Foods; United States | 2014 |
Equol, an isoflavone metabolite, regulates cancer cell viability and protein synthesis initiation via c-Myc and eIF4G.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Survival; Equol; Eukaryotic Initiation Factor-4G; Female; Gene Expression Regulation, Neoplastic; Glycine max; HeLa Cells; Humans; Isoflavones; Protein Biosynthesis; Proto-Oncogene Proteins c-myc; Receptors, Estrogen | 2015 |
Dietary soy isoflavones increase metastasis to lungs in an experimental model of breast cancer with bone micro-tumors.
Topics: Animals; Anticarcinogenic Agents; Bone Neoplasms; Breast Neoplasms; Cell Proliferation; Diet; Dietary Supplements; Disease Models, Animal; Equol; Female; Genistein; Isoflavones; Ki-67 Antigen; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Neoplasm Transplantation; Prognosis; Random Allocation; Soy Foods | 2015 |
Plasma equol concentration is not associated with breast cancer and fibrocystic breast conditions among women in Shanghai, China.
Topics: Adult; Breast Neoplasms; Breast Self-Examination; Case-Control Studies; China; Equol; Female; Fibrocystic Breast Disease; Humans; Isoflavones; Middle Aged; Odds Ratio | 2016 |
Daidzein-metabolizing phenotypes in relation to mammographic breast density among premenopausal women in the United States.
Topics: Adult; Breast; Breast Neoplasms; Equol; Female; Gas Chromatography-Mass Spectrometry; Humans; Hydroxyestrones; Isoflavones; Mammography; Middle Aged; Phenotype; Phytoestrogens; Soy Foods | 2009 |
Equol induces apoptosis through cytochrome c-mediated caspases cascade in human breast cancer MDA-MB-453 cells.
Topics: Apoptosis; Breast Neoplasms; Caspases; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Enzyme Activation; Equol; Humans; Isoflavones | 2009 |
Respective contribution exerted by AF-1 and AF-2 transactivation functions in estrogen receptor alpha induced transcriptional activity by isoflavones and equol: consequence on breast cancer cell proliferation.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Equol; Estrogen Receptor alpha; Female; Genistein; Humans; Isoflavones; Phosphorylation; Protein Structure, Tertiary; Transcriptional Activation | 2009 |
Delayed activation of extracellular-signal-regulated kinase 1/2 is involved in genistein- and equol-induced cell proliferation and estrogen-receptor-alpha-mediated transcription in MCF-7 breast cancer cells.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Equol; Estrogen Antagonists; Estrogen Receptor alpha; Extracellular Signal-Regulated MAP Kinases; Female; Genes, Reporter; Genistein; Humans; Isoflavones; Phosphorylation; Phytoestrogens; Protein Processing, Post-Translational; Time Factors; Transcriptional Activation | 2010 |
[Equol induced apoptosis of human breast cancer MDA-MB-231 cell by inhibiting the expression of nuclear factor-kappaB].
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Equol; Female; Humans; NF-kappa B; Phytoestrogens | 2011 |
[Effect of equol on breast tumors induced by 7, 12-dimethylbenz (α) anthracene in ovariectominzed rats].
Topics: Animals; Benz(a)Anthracenes; Breast Neoplasms; Equol; Female; Malondialdehyde; NF-E2-Related Factor 2; Ovariectomy; Rats; Rats, Sprague-Dawley | 2011 |
The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010).
Topics: Biological Availability; Breast Neoplasms; Cardiovascular Diseases; Dietary Supplements; Endometrial Neoplasms; Equol; Female; Glycine max; Humans; Isoflavones; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Risk Assessment; Soybean Proteins; Treatment Outcome; Women's Health | 2011 |
Effects of S-equol and natural S-equol supplement (SE5-OH) on the growth of MCF-7 in vitro and as tumors implanted into ovariectomized athymic mice.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Equol; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Ovariectomy; Receptors, Estrogen; Transcription, Genetic; Xenograft Model Antitumor Assays | 2011 |
Epigenetic modulation of BRCA1 and BRCA2 gene expression by equol in breast cancer cell lines.
Topics: Alleles; Antineoplastic Agents, Phytogenic; BRCA1 Protein; BRCA2 Protein; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; CpG Islands; Cytoplasm; DNA Methylation; Epigenesis, Genetic; Equol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Humans; Phytoestrogens; Promoter Regions, Genetic; Protein Transport; Up-Regulation | 2012 |
The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4G.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Dietary Supplements; Equol; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factor-4G; Female; Gene Expression Regulation, Neoplastic; Glycine max; Humans; Isoflavones; Mice; Mice, Nude; Neoplasm Transplantation; Phytoestrogens; Protein Biosynthesis; Proto-Oncogene Proteins c-myc; RNA, Messenger; RNA, Neoplasm; Transplantation, Heterologous; Up-Regulation | 2012 |
Development of a food compositional database for the estimation of dietary intake of phyto-oestrogens in a group of postmenopausal women previously treated for breast cancer and validation with urinary excretion.
Topics: Aged; Breast Neoplasms; Databases as Topic; Diet Records; Equol; Female; Food Analysis; Humans; Isoflavones; Middle Aged; Phytoestrogens; Postmenopause; Statistics, Nonparametric | 2013 |
Phytoestrogen concentrations in serum from Japanese men and women over forty years of age.
Topics: 4-Butyrolactone; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Chromans; Diet; Equol; Estrogens, Non-Steroidal; Female; Gas Chromatography-Mass Spectrometry; Genistein; Humans; Isoflavones; Japan; Lignans; Male; Middle Aged; Phytoestrogens; Plant Preparations; Prostatic Neoplasms; United Kingdom | 2002 |
Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women.
Topics: Aged; Biomarkers, Tumor; Breast; Breast Neoplasms; Cross-Sectional Studies; Dietary Supplements; Equol; Female; Gas Chromatography-Mass Spectrometry; Humans; Intestines; Isoflavones; Mammography; Middle Aged; Obesity; Phenotype; Phytoestrogens; Postmenopause; Soybean Proteins | 2004 |
Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice.
Topics: Animals; Breast Neoplasms; Cell Proliferation; Disease Progression; Dose-Response Relationship, Drug; Equol; Female; Humans; Isoflavones; Mice; Mice, Nude; Ovariectomy; Phytoestrogens; Transplantation, Heterologous | 2006 |
Soya isoflavones suppress phorbol 12-myristate 13-acetate-induced COX-2 expression in MCF-7 cells.
Topics: Anticarcinogenic Agents; Breast Neoplasms; Carcinogens; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Equol; Female; Genistein; Glycine max; Humans; Isoflavones; Membrane Proteins; Phytoestrogens; Plant Extracts; Promoter Regions, Genetic; Tetradecanoylphorbol Acetate | 2006 |
Equol: a comparison of the effects of the racemic compound with that of the purified S-enantiomer on the growth, invasion, and DNA integrity of breast and prostate cells in vitro.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Cell Line, Tumor; Comet Assay; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Equol; Female; Humans; Isoflavones; Male; Phytoestrogens; Prostatic Neoplasms; Receptors, Estrogen; Stereoisomerism | 2006 |
The effect of the phytoestrogens genistein, daidzein, and equol on the growth of tamoxifen-resistant T47D/PKC alpha.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Division; Cell Line, Tumor; Drug Interactions; Equol; Female; Genistein; Glycine max; Humans; Isoflavones; Mice; Mice, Nude; Random Allocation; Safety; Tamoxifen | 2007 |
Dietary and lifestyle correlates of urinary excretion status of equol in Japanese women.
Topics: Breast Neoplasms; Case-Control Studies; Cross-Sectional Studies; Dairy Products; Diet; Equol; Female; Humans; Isoflavones; Japan; Life Style; Menstrual Cycle; Middle Aged; Postmenopause; Smoking; Surveys and Questionnaires | 2008 |
Effect of sulphation on the oestrogen agonist activity of the phytoestrogens genistein and daidzein in MCF-7 human breast cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Equol; Estradiol; Estrogen Receptor alpha; Female; Genistein; Humans; Isoflavones; Phytoestrogens; Recombinant Proteins; Structure-Activity Relationship; Sulfates | 2008 |
Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer.
Topics: 4-Butyrolactone; Aged; Benzopyrans; Breast Neoplasms; Butylene Glycols; Chromans; Diet; Diet, Vegetarian; Dietary Fiber; Energy Intake; Equol; Female; Furans; Humans; Isoflavones; Lignans; Menopause; Menstruation; Middle Aged; Plant Extracts | 1982 |
Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro.
Topics: Anticarcinogenic Agents; Breast; Breast Neoplasms; Cell Division; Chromans; DNA, Neoplasm; Dose-Response Relationship, Drug; Epithelial Cells; Epithelium; Equol; Estradiol; Estrogen Antagonists; Estrogens, Non-Steroidal; Female; Flavonoids; Genistein; Humans; Isoflavones; Kaempferols; Phytoestrogens; Plant Preparations; Protein Binding; Quercetin; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 1997 |
Case-control study of phyto-oestrogens and breast cancer.
Topics: 4-Butyrolactone; Breast Neoplasms; Case-Control Studies; Chromans; Diet; Equol; Estrogens, Non-Steroidal; Female; Humans; Isoflavones; Lignans; Middle Aged; Phytoestrogens; Plant Preparations; Plants; Risk Factors | 1997 |
Differential effects of dietary phyto-oestrogens daidzein and equol on human breast cancer MCF-7 cells.
Topics: Breast Neoplasms; Chromans; Dose-Response Relationship, Drug; Equol; Estrogen Antagonists; Female; Humans; Isoflavones; Monoamine Oxidase Inhibitors; Neoplasm Proteins; Proteins; Receptors, Estrogen; RNA, Messenger; Tamoxifen; Trefoil Factor-1; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1997 |
Phytoestrogens have agonistic and combinatorial effects on estrogen-responsive gene expression in MCF-7 human breast cancer cells.
Topics: Breast Neoplasms; Chromans; Drug Interactions; Equol; Estrogens; Estrogens, Non-Steroidal; Gene Expression; Genistein; Humans; Isoflavones; Luciferases; Phytoestrogens; Plant Preparations; Transfection; Tumor Cells, Cultured | 1998 |
Reliability of serum measurements of lignans and isoflavonoid phytoestrogens over a two-year period.
Topics: 4-Butyrolactone; Adult; Age Factors; Aged; Bias; Breast Neoplasms; Chromans; Equol; Feasibility Studies; Female; Genistein; Humans; Isoflavones; Lignans; Middle Aged; New York City; Pilot Projects; Postmenopause; Premenopause; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 1998 |
Urinary excretion of isoflavonoids and the risk of breast cancer.
Topics: Adult; Anticarcinogenic Agents; Breast Neoplasms; Case-Control Studies; China; Chromans; Confidence Intervals; Creatinine; Equol; Estradiol; Estrogens, Non-Steroidal; Feeding Behavior; Female; Genistein; Glycine max; Humans; Isoflavones; Middle Aged; Monoamine Oxidase Inhibitors; Odds Ratio; Phenols; Risk Factors | 1999 |
Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer.
Topics: Adult; Breast Neoplasms; Chromans; Diet; Equol; Estrogens, Non-Steroidal; Female; Glycine max; Hormones; Humans; Isoflavones; Premenopause; Risk Factors; Sex Hormone-Binding Globulin | 2000 |
Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoestrogen equol.
Topics: 4-Butyrolactone; Benzopyrans; Breast Neoplasms; Butylene Glycols; Cell Division; Chromans; Equol; Estrogens; Female; Furans; Humans; Isoflavones; Lignans; Receptors, Progesterone; Tumor Cells, Cultured | 1987 |